AlphAIAlphAI — Financial news for AI agents
theglobeandmail.comOCT 31 min read

Ventas (VTR) Receives a Buy from BMO Capital

BMO Capital analyst Juan C. Sanabria reiterated a Buy rating on Ventas (VTR) with a $107.00 price target. Ventas reported Q2 revenue of $1.73B and net profit of $74.11M, up from $1.42B and $68.26M respectively last year. The consensus rating is Moderate Buy with a $99.93 target.

Original reporting
theglobeandmail.com
Published Oct 3, 2026, 12:41 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 3, 2026, 3:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Ventas (VTR) Receives a Buy from BMO Capital — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

Low
01

Why it matters

The article provides no new data beyond the already‑released earnings, offering limited trading insight.

02

Market read

Recap of Ventas' quarterly results and analyst rating; no fresh market‑moving information.

03

What to watch

None

Relevance 4/10Novelty 2/10Timing: today

Background

Analyst reiterates a Buy rating and cites Ventas' recent earnings numbers.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

None

Key entities

  • Company
    Ventas

    Real estate REIT discussed in the analyst note.

Read at source← All news

Related articles

OCT 13
$VTRMed

Ventas (VTR) Targets Up to 17% NOI Growth and Expands Acquisition Budget to $3 Billion

Ventas (VTR) targets 15-17% NOI growth and expands its acquisition budget to $3 billion, according to Guinness Global Real Assets Fund's Q3 2026 investor letter. The healthcare REIT's stock has traded between $67.36 and $101.60 over the past 52 weeks, closing at $83.54 on October 12, 2026, with a market cap of $43.11 billion. The fund notes potential benefits from improving senior housing occupancy and limited new supply.

finance.yahoo.com4 min
SEP 30
$WELLMedAI 8/10

The Senior Housing Boom Is Here. These 5 REITs Are Paying Investors to Ride It

Five senior housing REITs raised dividends in 2026, driven by strong demand. Welltower (WELL) and Ventas (VTR) lead in operating exposure, while Omega (OHI) and CareTrust (CTRE) focus on tenant credit and coverage. Dividend yields and coverage ratios vary, with Welltower offering the deepest buffer. Growth is fueled by acquisitions and equity raising, but risks include integration and operator stability.

247wallst.com3 min
SEP 18
$VTRHighAI 8/10

Ventas Stock: Is VTR Outperforming the Real Estate Sector?

Ventas, Inc. (VTR), a healthcare REIT, has outperformed the State Street Real Estate Select Sector SPDR ETF (XLRE) with a 29.6% gain over the past year. VTR's Q2 2026 earnings beat expectations, with revenue of $1.7 billion and adjusted FFO of $0.97. The company has a market cap of $45.2 billion and operates 1,450 properties. Analysts have a 'Strong Buy' consensus with a mean price target of $102, suggesting a 15.7% upside.

yahoo.com2 min
SEP 16
$WELLMedAI 8/10

The Baby Boomer Aging Wave Has Arrived. These 4 REITs Could Benefit for a Decade

Four REITs are positioned to benefit from the aging baby boomer population. Welltower (WELL) and Ventas (VTR) focus on senior housing, while Omega Healthcare (OHI) and CareTrust (CTRE) specialize in skilled nursing. Key metrics include occupancy rates, dividend coverage, and growth guidance. WELL and VTR show strong occupancy and FFO growth, while OHI and CTRE offer higher yields with varying risks.

247wallst.com3 min